CLC-2 Single Nucleotide Polymorphisms (SNPs) As Potential Modifiers of Cystic Fibrosis Disease Severity

Overview

Journal BMC Med Genet

Publisher Biomed Central

Specialty Genetics

Date 2004 Oct 28

PMID 15507145

Citations 7

Authors

Carol J Blaisdell

Timothy D Howard

Augustus Stern

Penelope Bamford

Eugene R Bleecker

O Colin Stine

Affiliations

Soon will be listed here.

Abstract

Background: Cystic fibrosis (CF) lung disease manifest by impaired chloride secretion leads to eventual respiratory failure. Candidate genes that may modify CF lung disease severity include alternative chloride channels. The objectives of this study are to identify single nucleotide polymorphisms (SNPs) in the airway epithelial chloride channel, CLC-2, and correlate these polymorphisms with CF lung disease.

Methods: The CLC-2 promoter, intron 1 and exon 20 were examined for SNPs in adult CF dF508/dF508 homozygotes with mild and severe lung disease (forced expiratory volume at one second (FEV1) > 70% and < 40%).

Results: PCR amplification of genomic CLC-2 and sequence analysis revealed 1 polymorphism in the hClC -2 promoter, 4 in intron 1, and none in exon 20. Fisher's analysis within this data set, did not demonstrate a significant relationship between the severity of lung disease and SNPs in the CLC-2 gene.

Conclusions: CLC-2 is not a key modifier gene of CF lung phenotype. Further studies evaluating other phenotypes associated with CF may be useful in the future to assess the ability of CLC-2 to modify CF disease severity.

Citing Articles

Research and progress on ClC‑2 (Review).

Wang H, Xu M, Kong Q, Sun P, Yan F, Tian W Mol Med Rep. 2017; 16(1):11-22.

PMID: 28534947 PMC: 5482133. DOI: 10.3892/mmr.2017.6600.

Chloride channelopathies of ClC-2.

Bi M, Hong S, Zhou H, Wang H, Wang L, Zheng Y Int J Mol Sci. 2014; 15(1):218-49.

PMID: 24378849 PMC: 3907807. DOI: 10.3390/ijms15010218.

The ABCC6 transporter: what lessons can be learnt from other ATP-binding cassette transporters?.

Vanakker O, Hosen M, De Paepe A Front Genet. 2013; 4:203.

PMID: 24137173 PMC: 3797522. DOI: 10.3389/fgene.2013.00203.

Genetic influences on cystic fibrosis lung disease severity.

Weiler C, Drumm M Front Pharmacol. 2013; 4:40.

PMID: 23630497 PMC: 3632778. DOI: 10.3389/fphar.2013.00040.

Genetic variation and clinical heterogeneity in cystic fibrosis.

Drumm M, Ziady A, Davis P Annu Rev Pathol. 2011; 7:267-82.

PMID: 22017581 PMC: 4029837. DOI: 10.1146/annurev-pathol-011811-120900.

References

Blaisdell C, Edmonds R, Wang X, Guggino S, Zeitlin P . pH-regulated chloride secretion in fetal lung epithelia. Am J Physiol Lung Cell Mol Physiol. 2000; 278(6):L1248-55. DOI: 10.1152/ajplung.2000.278.6.L1248. View

Grasemann H, Vans Gravesande K, Buscher R, Knauer N, Silverman E, Palmer L . Endothelial nitric oxide synthase variants in cystic fibrosis lung disease. Am J Respir Crit Care Med. 2002; 167(3):390-4. DOI: 10.1164/rccm.200202-155OC. View

Bosl M, Stein V, Hubner C, Zdebik A, Jordt S, Mukhopadhyay A . Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl(-) channel disruption. EMBO J. 2001; 20(6):1289-99. PMC: 145530. DOI: 10.1093/emboj/20.6.1289. View

Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J . Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet. 2001; 27(4):383-91. DOI: 10.1038/86882. View

Lamb F, Graeff R, Clayton G, Smith R, Schutte B, McCray Jr P . Ontogeny of CLCN3 chloride channel gene expression in human pulmonary epithelium. Am J Respir Cell Mol Biol. 2001; 24(4):376-81. DOI: 10.1165/ajrcmb.24.4.4114. View

Henry M, CAVE S, Rendall J, OConnor C, Morgan K, Fitzgerald M . An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis. Eur J Hum Genet. 2001; 9(4):273-8. DOI: 10.1038/sj.ejhg.5200623. View

Edmonds R, Silva I, Guggino W, Butler R, Zeitlin P, Blaisdell C . ClC-5: ontogeny of an alternative chloride channel in respiratory epithelia. Am J Physiol Lung Cell Mol Physiol. 2002; 282(3):L501-7. DOI: 10.1152/ajplung.00207.2001. View

Fuller C, Ji H, Tousson A, Elble R, Pauli B, Benos D . Ca(2+)-activated Cl(-) channels: a newly emerging anion transport family. Pflugers Arch. 2002; 443 Suppl 1:S107-10. DOI: 10.1007/s004240100655. View

Berger M . Inflammatory mediators in cystic fibrosis lung disease. Allergy Asthma Proc. 2002; 23(1):19-25. View

10.

Nehrke K, Arreola J, Nguyen H, Pilato J, Richardson L, Okunade G . Loss of hyperpolarization-activated Cl(-) current in salivary acinar cells from Clcn2 knockout mice. J Biol Chem. 2002; 277(26):23604-11. DOI: 10.1074/jbc.M202900200. View

11.

Varela D, Niemeyer M, Cid L, Sepulveda F . Effect of an N-terminus deletion on voltage-dependent gating of the ClC-2 chloride channel. J Physiol. 2002; 544(2):363-72. PMC: 2290594. DOI: 10.1113/jphysiol.2002.026096. View

12.

Haug K, Warnstedt M, Alekov A, Sander T, Ramirez A, Poser B . Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet. 2003; 33(4):527-32. DOI: 10.1038/ng1121. View

13.

Mall M, Gonska T, Thomas J, Schreiber R, Seydewitz H, Kuehr J . Modulation of Ca2+-activated Cl- secretion by basolateral K+ channels in human normal and cystic fibrosis airway epithelia. Pediatr Res. 2003; 53(4):608-18. DOI: 10.1203/01.PDR.0000057204.51420.DC. View

14.

Merlo C, Boyle M . Modifier genes in cystic fibrosis lung disease. J Lab Clin Med. 2003; 141(4):237-41. DOI: 10.1067/mlc.2003.29. View

15.

Chu S, Cockrell C, Ferro T . Expression of alpha-ENaC2 is dependent on an upstream Sp1 binding motif and is modulated by protein phosphatase 1 in lung epithelial cells. Biochem Biophys Res Commun. 2003; 303(4):1159-68. DOI: 10.1016/s0006-291x(03)00497-2. View

16.

Holmes K, Hales R, Chu S, Maxwell M, Mogayzel Jr P, Zeitlin P . Modulation of Sp1 and Sp3 in lung epithelial cells regulates ClC-2 chloride channel expression. Am J Respir Cell Mol Biol. 2003; 29(4):499-505. DOI: 10.1165/rcmb.2003-0030OC. View

17.

Hurbain I, Sermet-Gaudelus I, Vallee B, Feuillet M, Lenoir G, Bernaudin J . Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the delta F508 mutation. Pediatr Res. 2003; 54(5):627-34. DOI: 10.1203/01.PDR.0000090926.16166.3F. View

18.

Quinton P . Cystic fibrosis: a disease in electrolyte transport. FASEB J. 1990; 4(10):2709-17. DOI: 10.1096/fasebj.4.10.2197151. View

19.

Zeitlin P, Lu L, Rhim J, Cutting G, Stetten G, Kieffer K . A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol. 1991; 4(4):313-9. DOI: 10.1165/ajrcmb/4.4.313. View

20.

Knowles M, Clarke L, Boucher R . Extracellular ATP and UTP induce chloride secretion in nasal epithelia of cystic fibrosis patients and normal subjects in vivo. Chest. 1992; 101(3 Suppl):60S-63S. DOI: 10.1378/chest.101.3_supplement.60s. View